The Rationale for Targeting the NAD/NADH Cofactor Binding Site of Parasitic S-Adenosyl-L-homocysteine Hydrolase for the Design of Anti-parasitic Drugs

Similar Items

• The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi
  od: Cai, Sumin, i dr.
  Izdano: (2007)
• Evaluation of NAD(H) analogues as selective inhibitors for Trypanosoma cruzi S-Adenosylhomocysteine hydrolase
  od: Li, Qing-Shan, i dr.
  Izdano: (2009)
• Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 3. The role of lysyl and tyrosyl residues of the C-terminal extension
  od: Cai, Sumin, i dr.
  Izdano: (2010)
• S-Adenosyl-L-Homocysteine Hydrolase Inhibition by a Synthetic Nicotinamide Cofactor Biomimetic
  od: Kailing, Lyn L., i dr.
  Izdano: (2018)
• Crystallization of mouse S-adenosyl-l-homocysteine hydrolase
  od: Ishihara, Masaaki, i dr.
  Izdano: (2010)